Regulus Therapeutics

1 follower

‌

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.

Industries

Biotechnology, Education

Headquarters

San Diego, United States

Employees

51-200

Links

Org chart

Jay Hagan

President & CEO

Jay Hagan

Collapse

Preston S. Klassen

President & Head of Reserach & Development

Cris Calsada

CFO

Curtis Monnig

VP & CMC

Christopher Aker

SVP & General Counsel

Rekha Garg

SVP, Clinical Development & Regulatory

Claire Padgett

SVP, Clinical Operations

Amin Kamel

VP, Drug Metabolism & Pharmacokinetics

Brian Campion

VP, Business Development

Moh Ahmadian

VP, Chemistry & Pharmaceutical Development

Edmund Lee

VP, Translational Medicine

Teams

Legal and Compliance

9 members

Drug Development and Pharmacology

8 members

Leadership Team

6 members

Similar companies

Bravado

6 followers

Invivyd

1 follower

Abeona Therapeutics

1 follower

Annexon Biosciences

2 followers

Immunai

2 followers

Goalbook

1 follower

VentureWell

1 follower

Rethink Ed

1 follower

Thermo Fisher Scientific

155 followers

Agilent Technologies

63 followers

Myriad Genetics

35 followers

Explore companies